This is a fair assessment. I see SP of $20 easy for the entire HIV space. Yes, cancer is another world. As below article bemoans, billions spent with very little progress compared to the research. The quickest way to get there will be with a partner. I hope we find one to get us there faster to save lives faster. Once we get results for the additional patients being dosed, we will be closer to realizing higher SP-Assuming they are as promising as the first 2. Other key events will be BLA submission, FDA approval, and up listing to Nasdaq. That is when this thing will really take off.
MrGuru, keep in mind we give up another 8.5% total in royalty payments from Progenics and AbbVie Inc of net sales per the 10Q, that takes us down to 41.5%.